CORRECTION – Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB) [Yahoo! Finance]
Enveric Biosciences, Inc. (ENVB)
Company Research
Source: Yahoo! Finance
replaced and includes the correct amount paid upfront for sponsored research, disregard all previous press release Disclosures on this ticker. The corrected release follows: NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB). The update note includes information on the Enveric Bioscience's management commentary, recent developments, outlook, and risks. The full research report is available here . Highlights from the report include: Enveric Sells Cancer-Targeting Cannabinoid-Related Intellectual Property: Enveric Biosciences has announced the sale of one of its cancer-related patent portfolios for an undisclosed sum, emphasizing its strategic pivot towards advancing its neuroplastogenic small-molecule therapeutics for mental health disorders, including depression, anxiety, and addiction. The divested portfolio
Show less
Read more
Impact Snapshot
Event Time:
ENVB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ENVB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ENVB alerts
High impacting Enveric Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
ENVB
News
- Enveric Biosciences, Inc. (ENVB) Stock Declines While Market Improves: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- What Makes Enveric Biosciences (ENVB) a New Strong Buy Stock [Yahoo! Finance]Yahoo! Finance
- Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023 [Yahoo! Finance]Yahoo! Finance
- Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023Business Wire
- Enveric gains on out-licensing deal of new chemical entities for joint disease treatments [Seeking Alpha]Seeking Alpha
ENVB
Sec Filings
- 4/16/24 - Form ARS
- 4/16/24 - Form DEF
- 3/28/24 - Form 8-K
- ENVB's page on the SEC website